BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1 AND Staging
2309 results:

  • 1. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
    Zhang H; He X; Miao Q; Li L; Song J; Jiang X
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
    Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
    J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
    Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
    World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
    Lau WC; Huang L; Zheng X; Ming WK; Leong NC; Tak Wong Y; Yin Z; Yu H; Lyu J; Deng L
    Front Endocrinol (Lausanne); 2024; 15():1260966. PubMed ID: 38572477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
    Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
    Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 7. Single-cell Transcriptome Analysis of Small cell Neuroendocrine Carcinoma of the Endometrium Reveals
    Zhong C; Guo YE; Yang Q; Song Y; Wang T; Cai B; Chen H; Du H; Wan J; Liu Y; Li Y; Wan X
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):100. PubMed ID: 38538277
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
    Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
    Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of Social Vulnerabilities of Care and Prognosis in Adult Ocular Melanomas in the US.
    Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
    Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
    Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
    Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.
    Michalski K; Schlötelburg W; Hartrampf P; Heinrich M; Serfling S; Buck AK; Werner RA; Kosmala A; Weich A
    Mol Imaging Biol; 2024 Apr; 26(2):344-350. PubMed ID: 38332341
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
    O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
    Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A pancancer analysis of the clinical and genomic characteristics of multiple primary cancers.
    Zhang B; He L; Zhou C; Cheng X; Li Q; Tang Y; Li F; Huang T; Tu S
    Sci Rep; 2024 Jan; 14(1):2367. PubMed ID: 38287125
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era.
    Hagopian G; Jiang X; Grant C; Brazel D; Kumar P; Yamamoto M; Jakowatz J; Chow W; Tran T; Shen W; Moyers J
    ESMO Open; 2024 Feb; 9(2):102193. PubMed ID: 38271786
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Retinoblastoma treatment in a Brazilian population. Presentation and long-term results.
    Bonanomi MTBC; de Almeida MTA; Hollaender MA; Bonanomi RC; Monteiro MLR
    Cancer Med; 2024 Feb; 13(3):e6683. PubMed ID: 38243643
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Simultaneous melanomas in the setting of multiple primary melanomas.
    Kostaki M; Plaka M; Befon A; Dessinioti C; Kypraiou K; Chardalia V; Christofidou E; Polydorou D; Stratigos A
    Melanoma Res; 2024 Apr; 34(2):198-201. PubMed ID: 38224405
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
    Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
    Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma.
    Rodrigues MMC; Lederman HM; Grossman I; Castiglioni MLV; Marchetti R; Grass DC; Luisi FAV; Caran EMM
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30820. PubMed ID: 38153317
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 116.